|Lecture Notes: 1 December||
Since the Glycogen synthase and phosphorylase reactions are in opposition we need a control system. Glycogen storage/release strategies vary widely with different tissues. In liver, glycogen is used to provide glucose to the serum between meals - it serves a homeostatic function. Glycogen control in liver is thus designed to breakdown and release glycogen when serum [glucose] is low and synthesize glycogen when serum [glucose] is high.
The net result is that glycogen is synthesized when [glucose] is hi, and it is broken down when [glucose] is low.
In muscle it turns out that glycogen synthesis/breakdown is controlled by a very complex system enabling both rapid response to emergencies and exquisite overall control of the opposing activities to respond to a variety of situations. This is accomplished through the Glycogen Cascade Control system. (The diagram shown is actually a simplified representation, especially of the synthase enzyme, which turns out to have 9 phosphorylatable sites which are phosphorylated by a number of different kinases responding to different complex physiological situations and with varying responses by the enzyme.)
Response begins with a hormonal signal, such as adrenalin, binding to the receptor on the cell surface. This results in the phosphorylation of GDP to GTP on an intracellular G-protein. The G-protein can now interact with Adenylate cyclase to produce the "second messenger" 3', 5'- cyclic AMP (cAMP). Cyclic AMP then binds to the regulatory subunit of cAMP-dependent protein kinase, releasing the active catalytic subunits (C), which can now phosphorylate inactive o-phosphorylase kinase b to the active m-phosphorylase kinase a (o= original, m= modified, b= inactive, a= active). Phosphorylase kinase a then phosphorylates o-Glycogen phosphorylase b to the active m-Glycogen phosphorylase a, resulting in the breakdown of glycogen with the release of G-1-P.
Note the parallel kinase cascade which simultaneously shuts down Glycogen synthase.
Finally, one does not always have a warning, that is time to get the endocrine system going to produce adrenalin, thus the release of calcium in the muscle cells bypasses much of the cascade, activating the normally inactive o-phosphorylase kinase b, which then acts on both the phosphorylase and the synthase.
The Pentose Phosphate Pathway is an alternate pathway for glucose oxidation which is used to provide reducing equivalents in support of biosynthesis. Thus although it involves the catabolism of glucose, it is generally going to be active only when anabolism is taking place.
This pathway is usually treated in two parts: the oxidative portion, and the sugar interconversions portion. In the oxidative part, on the top of the handout, glucose is first oxidized to a lactone, and then oxidatively decarboxylated. Note that in each case NADP+ is the oxidant as opposed to NAD+. Note also that the two DH reactions are both physiologically irreversible, due in part to the very low concentrations of NADPH in cells.
The first enzyme, G-6-P DH, is highly specific for glucose (it is frequently used as the basis of specific glucose assays). In this reaction the #1 (aldehydic) carbon of glucose is oxidized to a lactone (cyclized carboxylic acid).
Next Gluconolactonase opens the ring with the addition of a molecule of water. Then 6-P-gluconate DH oxidizes the #3 carbon to a ketone. This results in the #2 carbon becoming somewhat acidic, thus destabilizing the carboxyl group, which is then lost to give the five carbon ribulose-5-P.
In the non-oxidative portion of the Pentose Phosphate Pathway a series of sugar interconversions takes the RU-5-P to intermediates of other pathways: Ribose-5-P for nucleotide biosynthesis, and F-6-P and Ga-3-P for glycolysis/gluconeogenesis. All of these reactions are near equilibrium, with fluxes driven by supply and use of the three intermediates listed above.
Last modified 2 December 2008